KUVATRIS THERAPEUTICS, INC. Retained Earnings
KUVATRIS THERAPEUTICS, INC. had Retained Earnings of -$59.60 million as of 2024-09-30, per its 10-Q filed 2026-01-14.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:RetainedEarningsAccumulatedDeficit · last filed 2026-01-14
- 2024-09-30: Retained Earnings (Accumulated Deficit) -$59.60M.
- 2024-06-30: Retained Earnings (Accumulated Deficit) -$58.72M.
- 2024-03-31: Retained Earnings (Accumulated Deficit) -$55.72M.
- 2023-12-31: Retained Earnings (Accumulated Deficit) -$52.03M.
| Period end | Retained Earnings (Accumulated Deficit) |
|---|---|
| 2024-09-30 | -$59.60M 10-Q · filed 2026-01-14 |
| 2024-06-30 | -$58.72M 10-Q · filed 2024-09-20 |
| 2024-03-31 | -$55.72M 10-Q · filed 2024-05-13 |
| 2023-12-31 | -$52.03M 10-Q · filed 2026-01-14 |
| 2023-09-30 | -$46.11M 10-Q · filed 2023-11-16 |
| 2023-06-30 | -$41.06M 10-Q · filed 2023-08-09 |
| 2023-03-31 | -$37.57M 10-Q · filed 2023-05-15 |
| 2022-12-31 | -$33.74M 10-K · filed 2024-03-11 |
| 2022-09-30 | -$28.52M 10-Q · filed 2022-11-14 |
| 2022-06-30 | -$17.06M 10-Q · filed 2022-09-30 |
| 2021-12-31 | -$18.94M 10-K · filed 2023-03-30 |